T Miyata

1.7k total citations
33 papers, 1.4k citations indexed

About

T Miyata is a scholar working on Clinical Biochemistry, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, T Miyata has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Clinical Biochemistry, 8 papers in Surgery and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in T Miyata's work include Advanced Glycation End Products research (13 papers), Natural Antidiabetic Agents Studies (8 papers) and Electrospun Nanofibers in Biomedical Applications (6 papers). T Miyata is often cited by papers focused on Advanced Glycation End Products research (13 papers), Natural Antidiabetic Agents Studies (8 papers) and Electrospun Nanofibers in Biomedical Applications (6 papers). T Miyata collaborates with scholars based in Japan, Belgium and United States. T Miyata's co-authors include Masaomi Nangaku, Kiyoshi Kurokawa, Charles van Ypersele de Strihou, Katsunori Horie, Kiyoshi Kurokawa, Kenji Maeda, Shuichi Tanaka, Yoshinari Yasuda, Kentaroh Yoshida and Kazuo Kurokawa and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

T Miyata

33 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Miyata Japan 18 646 304 264 238 198 33 1.4k
Ping Xie United States 20 201 0.3× 320 1.1× 132 0.5× 650 2.7× 132 0.7× 46 1.7k
Bernd Stratmann Germany 23 464 0.7× 45 0.1× 664 2.5× 451 1.9× 325 1.6× 66 2.0k
Galina Shapiro Israel 19 69 0.1× 187 0.6× 190 0.7× 391 1.6× 159 0.8× 39 1.5k
Hiroki Tsuchida Japan 17 147 0.2× 164 0.5× 145 0.5× 336 1.4× 158 0.8× 47 923
Angela M. Carter United Kingdom 20 276 0.4× 59 0.2× 192 0.7× 392 1.6× 169 0.9× 36 1.7k
Yasuhiro Hamada Japan 22 273 0.4× 446 1.5× 164 0.6× 555 2.3× 334 1.7× 77 1.9k
Hidetaka Nakayama Japan 16 345 0.5× 56 0.2× 493 1.9× 224 0.9× 210 1.1× 33 1.0k
Carmen Herencia Spain 20 70 0.1× 592 1.9× 101 0.4× 557 2.3× 94 0.5× 37 1.9k
Petra Šimić Croatia 18 70 0.1× 253 0.8× 145 0.5× 916 3.8× 170 0.9× 38 1.8k
Francesco Addabbo Italy 23 61 0.1× 166 0.5× 108 0.4× 642 2.7× 258 1.3× 56 1.6k

Countries citing papers authored by T Miyata

Since Specialization
Citations

This map shows the geographic impact of T Miyata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Miyata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Miyata more than expected).

Fields of papers citing papers by T Miyata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Miyata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Miyata. The network helps show where T Miyata may publish in the future.

Co-authorship network of co-authors of T Miyata

This figure shows the co-authorship network connecting the top 25 collaborators of T Miyata. A scholar is included among the top collaborators of T Miyata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Miyata. T Miyata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Izuhara, Y., Masaomi Nangaku, Shunya Takizawa, et al.. (2007). A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models. Nephrology Dialysis Transplantation. 23(2). 497–509. 32 indexed citations
2.
Miyata, T, Kiyoshi Kurokawa, & C. van Ypersele de Strihou. (2005). From Molecular Footprints of Disease to New Therapeutic Interventions in Diabetic Nephropathy: A Detective Story. PubMed. 5(3). 323–329. 3 indexed citations
3.
Miyata, T, Charles van Ypersele de Strihou, Toshiyuki Imasawa, et al.. (2001). Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient. Kidney International. 60(6). 2351–2359. 81 indexed citations
4.
Miyata, T, Satoshi Sugiyama, Akira Saito, & Kiyoshi Kurokawa. (2001). Reactive carbonyl compounds related uremic toxicity (“carbonyl stress”). Kidney International. 59. S25–S31. 83 indexed citations
5.
Miyata, T, Katsunori Horie, Yuji Fujita, et al.. (2000). Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney International. 58(1). 425–435. 106 indexed citations
6.
Asahi, Koichi, Kohji Ichimori, Hiroe Nakazawa, et al.. (2000). Nitric oxide inhibits the formation of advanced glycation end products. Kidney International. 58(4). 1780–1787. 36 indexed citations
7.
Izuhara, Y., T Miyata, Yoshimichi Ueda, et al.. (1999). A Sensitive and specific ELISA for plasma pentosidine. Nephrology Dialysis Transplantation. 14(3). 576–580. 28 indexed citations
8.
Akhand, Anwarul Azim, Haruhiko Suzuki, Wei Liu, et al.. (1999). Carbonyl compounds cross-link cellular proteins and activate protein-tyrosine kinase p60c-Src. Journal of Cellular Biochemistry. 72(1). 1–7. 55 indexed citations
9.
Hiroi, Miki, et al.. (1998). Re-evaluation of the culture condition of polymorphonuclear cells for the study of apoptosis induction.. PubMed. 18(3A). 1813–8. 6 indexed citations
10.
Niwa, Hisayoshi, Masakazu Wakai, T Miyata, et al.. (1998). Accelerated Formation of Nϵ-(carboxymethyl) Lysine, an Advanced Glycation End Product, by Glyoxal and 3-Deoxyglucosone in Cultured Rat Sensory Neurons. Biochemical and Biophysical Research Communications. 248(1). 93–97. 53 indexed citations
11.
Miyata, T, et al.. (1998). Increased Pentosidine, an Advanced Glycation End Product, in Plasma and Synovial Fluid from Patients with Rheumatoid Arthritis and Its Relation with Inflammatory Markers. Biochemical and Biophysical Research Communications. 244(1). 45–49. 128 indexed citations
12.
Miyata, T, Katsunori Horie, Masaomi Nangaku, et al.. (1998). Renal catabolism of advanced glycation end products: The fate of pentosidine. Kidney International. 53(2). 416–422. 182 indexed citations
13.
Yasuda, Takeshi, T Miyata, Keiko Mizuno, et al.. (1996). Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain. Neuroscience Letters. 221(1). 17–20. 58 indexed citations
14.
Noishiki, Yasuharu, et al.. (1994). A New Cardiac Wall Substitute with High Affinity for Fibroblasts that Can Induce an Endothelial Cell Lining. ASAIO Journal. 40(3). M751–M756. 4 indexed citations
15.
Ichikawa, Yuji, et al.. (1993). Comparative analysis of mechanical and biological properties of a pure collagen coated ultrafine polyester fiber graft versus Gelseal® graft. 22(2). 440–444. 1 indexed citations
16.
Noishiki, Yasuharu, et al.. (1990). A new bioprosthetic cardiac valve with reduced calcification.. PubMed. 36(3). M411–4. 19 indexed citations
17.
Miyata, T. (1989). Collagen and Fibrin. JAPANES JOURNAL OF MEDICAL INSTRUMENTATION. 59(3). 154–162. 1 indexed citations
18.
Minabe, Masato, et al.. (1989). Different Cross‐Linked Types of Collagen Implanted in Rat Palatal Gingiva. Journal of Periodontology. 60(1). 35–43. 75 indexed citations
19.
Miyata, T, et al.. (1976). Deposition of platelets and fibrin on chemically modifide collagen hollow fibers.. PubMed. 22. 261–8. 9 indexed citations
20.
Miyata, T, et al.. (1968). Studies on collagen implants in the vitreous.. PubMed. 19. 492–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026